GENEYE GCP-30 – Rapid Multiplex Molecular Testing in UAE

InstaMed Medical Equipment Trading LLC provides the GENEYE® GCP-30 from GenDx Biotech, an advanced rapid molecular Point-of-Care Testing (POCT) platform designed for fast detection of infectious disease pathogens.

The compact GCP-30 combines a simple sample-to-result workflow with multiplex molecular detection, delivering results within 20 minutes, with less than 1 minute of hands-on time and the capability to detect up to 30 targets in a single run.

For laboratories, hospitals and clinics looking for a faster alternative to conventional molecular workflows, GENEYE brings molecular testing closer to the point of care.

20 Minutes. Multiplex Molecular Results.

Within 20 minutes
Rapid sample-to-result molecular testing.

Less than 1 minute hands-on time
Designed to minimize manual processing.

Up to 30 targets
Multiplex detection capability on a compact platform.

Compact POCT System
GCP-30 weighs approximately 4 kg with a footprint of only 245 × 200 × 145 mm.

Lyophilized Reagents
Manufacturer specifies reagent transportation below 30°C, helping simplify logistics compared with conventional cold-chain-dependent workflows.

Rapid Molecular Testing Without a Conventional PCR Workflow

GENEYE is based on GenDx Biotech’s ERA – Enzymatic Rapid Amplification – molecular technology and real-time fluorescence detection. GenDx positions its GENEYE systems specifically for rapid on-site pathogen detection and molecular POCT applications.

Available GENEYE Molecular Assays

Respiratory Pathogen Panel – 15 Targets

The GENEYE Respiratory ERA Panel (RPD15) provides broad multiplex detection for major viral and bacterial respiratory pathogens.

It covers:

Influenza A • Influenza B • RSV • SARS-CoV-2 • Human Adenovirus • Parainfluenza Virus • Chlamydia pneumoniae • Mycoplasma pneumoniae • Streptococcus pneumoniae • Human Coronaviruses NL63, HKU1, 229E and OC43 • Human Rhinovirus • Haemophilus influenzae • Bordetella pertussis • Human Bocavirus • Human Metapneumovirus.

Rapid Respiratory 6 Panel

For more focused respiratory testing, the Resp-6-ERA panel covers Influenza A, Influenza B, SARS-CoV-2, RSV, Parainfluenza Virus and Human Metapneumovirus.

Rapid STI Molecular Panel – 10 Targets

The GENEYE Sexually Transmitted Infection ERA Panel (STD10) provides simultaneous molecular detection of 10 important sexually transmitted and genital pathogens:

Chlamydia trachomatis • Neisseria gonorrhoeae • Mycoplasma genitalium • Ureaplasma urealyticum • Gardnerella vaginalis • Trichomonas vaginalis • Herpes Simplex Virus II • Treponema pallidum • Candida • Human Cytomegalovirus.

One rapid molecular panel. Multiple STI targets. Results within the GCP-30 rapid workflow.

HPV Molecular Testing

Up to 20 Genotypes

GENEYE HPV E6/E7 Typing Super Panel

The HPV20 panel provides multiplex detection of 20 HPV genotypes:

HPV 6, 11, 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73 and 82.

GENEYE HPV 14 Panel

A focused HPV panel is also available covering HPV 16, HPV 18 and 12 additional HPV types including 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.

Rapid Vaginitis Molecular Panel

The GENEYE Vaginitis Microbial ERA Assay simultaneously detects:

Candida albicans • Candida glabrata • Trichomonas vaginalis • Gardnerella vaginalis.

A rapid multiplex molecular approach can help laboratories consolidate common vaginitis targets into a single workflow.

CARBA 5 – Carbapenemase Resistance Gene Detection

The GENEYE CARBA 5 ERA Assay covers five major carbapenemase resistance markers:

KPC • NDM • OXA-48 • VIM • IMP.

Vector-Borne Disease Molecular Testing

The GENEYE Vector-Borne Pathogen ERA Assay provides rapid molecular testing covering pathogens associated with:

Dengue • Zika • Chikungunya • Yellow Fever • West Nile Virus • Plasmodium falciparum • Plasmodium vivax.

Additional GENEYE Panels

The current GCP-30 brochure also lists:

TORCH ERA Assay – RUO
Toxoplasma gondii, Treponema pallidum, Varicella-Zoster Virus, Rubella Virus, Cytomegalovirus and Herpes Simplex Virus.

FEVER ID ERA Assay – RUO
Plasmodium falciparum, Plasmodium vivax, Dengue Virus and Salmonella Typhi.

Designed for Rapid Molecular POCT

GENEYE GCP-30 is particularly suitable for laboratories and healthcare facilities looking to introduce rapid molecular testing without the workflow complexity and long turnaround time associated with many conventional molecular platforms.

Potential applications include:

1. ✦ Rapid respiratory infection testingSTI molecular diagnostics
2. ✦ HPV genotyping
3. ✦ Vaginitis molecular testing
4. ✦ Antimicrobial resistance / CARBA testing
5. ✦ Vector-borne disease detection
6. ✦ Women’s health molecular diagnostics
7. ✦ Decentralized and near-patient molecular testing

Why GENEYE GCP-30?

Rapid – results within 20 minutes
Multiplex – platform capability of up to 30 targets per run
Simple – less than one minute hands-on time
Compact – approximately 4 kg desktop system
Flexible – multiple infectious disease and women’s health panels
POCT focused – designed for molecular testing closer to the patient
Easy logistics – lyophilized reagents specified for transportation below 30°C

The manufacturer also states a reported analytical detection capability of up to 500 copies/mL, depending on assay specifications.

GENEYE GCP-30 Representative UAE

InstaMed Medical Equipment Trading LLC supplies and supports GenDx Biotech GENEYE molecular POCT solutions in the UAE.

Our team can support laboratories with product evaluation, demonstrations, assay selection, installation, application support and after-sales service.

Looking for a rapid molecular POCT system in the UAE?

Contact InstaMed to discuss the GENEYE GCP-30, available molecular panels and your laboratory’s testing requirements.